Nippon Medical School is a private university in Sendagi, Bunkyo-ku, Tokyo, Japan.

During the past decade, Nippon Medical School conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nippon Medical School" #1 sponsor was "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 3 trials, followed by "Baxter Healthcare Corporation" with 1 trials sponsored, "HeadSense Medical" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored and "Nippon Medical School" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nippon Medical School" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator, "A2 Healthcare Taiwan Corporation" with 1 trials as a collaborator, "Chiba University, Japan" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "HOSEI University, Japan" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Nippon Medical School" are "Colorectal Cancer" (2 trials), "Anesthesia" (1 trials), "Atrial Fibrillation Non-Rheumatic" (1 trials), "Brain Injuries" (1 trials) and "Brain Neoplasms" (1 trials). Many other conditions were trialed in "Nippon Medical School" in a lesser frequency.

Most popular intervention types in "Nippon Medical School" are "Drug" (5 trials), "Procedure" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "UFT adjuvant chemotherapy" (2 trials), "Catheter ablation" (1 trials), "HS-1000" (1 trials), "Permanent iodine-125 (Brachytherapy)" (1 trials) and "Placebo+Tegaderm" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nippon Medical School" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nippon Medical School". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Nippon Medical School, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nippon Medical School, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".